Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study
Context: We previously designed, developed and characterized a novel microencapsulated formulation as a platform for the targeted delivery of Probucol (PB) in an animal model of Type 2 Diabetes. Objective: The objective of this study is to optimize this platform by incorporating Chenodeoxycholic aci...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Taylor and Francis Ltd
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/44153 |